Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Cancer Research Communications

Comparative Analysis of Ovarian Cancer Tumor-Infiltrating T Cells with Those in Melanoma and before and after PD-1 Blockade

10 more authors
12 affiliations
  1. 1Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.
  2. 2Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  3. 3Department of Immunology, University of Toronto, Toronto, Canada.
  4. 4Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Canada.
  5. 5Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  6. 6Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  7. 7Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Research Institute, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Canada.
  8. 8Department of Microbiology, Immunology and Infectious Disease, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  9. 9Alberta Children’s Hospital Research Institute, Calgary, Canada.
  10. 10Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Canada.
  11. 11Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  12. 12Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada.

Abstract

CD8+ T cells are involved in natural tumor immune surveillance and are known to play a critical role in mediating responses to programmed cell death protein 1 (PD-1) blockade. High-grade serous ovarian cancer (HGSOC) exhibits intrinsic resistance to immune checkpoint inhibitors (ICI), despite the presence of tumor-infiltrating lymphocytes (TIL) in the tumor immune microenvironment (TIME). In this study, we characterized the phenotype and frequency of TILs in the tumor samples of patients with HGSOC and compared our findings with TILs from melanoma, a tumor highly sensitive to ICI. Melanoma harbored an increased density of CD8+ TILs compared with HGSOC. However, CD8+ T cells from HGSOC tumor samples expressed higher levels of exhaustion markers such as 2B4 and PD-1 compared with the CD8+ melanoma TILs, with evidence for antigen-specific CD8+ TILs. Our study demonstrates that despite the presence of CD8+ T cells that are phenotypically exhausted, there is limited expansion of CD8+ cells after treatment with anti–PD-1 in patients with HGSOC. These data indicate that CD8+ T cells from ovarian cancer express markers associated with antigen specificity and are on the exhaustion trajectory yet are unable to contribute to a measurable antitumor response after PD-1 blockade.

Significance:: By analyzing the TIME in patient-derived samples of HGSOC and comparing them with melanoma, we identify a lower density of CD8+ cells. These cells are characterized by a higher level of immune exhaustion with a poor response after treatment with anti–PD-1.

Related

  1. Patient-Derived Melanoma Organoids Preserve Tumor-Immune Heterogeneity and Reveal Context-Dependent Responses to Immune Checkpoint Blockade
    M. Serasanambati, J. Chadokiya, M. Nakano +8
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. 830 mLIGHT-armed oncolytic myxoma virus combined with selinexor and PD-1 blockade reduces pulmonary metastatic burden in an immunocompetent murine melanoma model
    Deon Nguyen, Manuel Cias Marquez, Ami D Gutierez-Jensen +2
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textGenetics & genomicsDOAJ
  3. Redox Storm in the Tumor Microenvironment (ΤΜΕ): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface
    Vasileios Alexandros Karakousis, Antonia Sioga, Ioannis S. Vizirianakis +4
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  4. Mesenchymal Stromal Cells‐Mediated Tumor‐Targeted Delivery of Oncolytic Bacteria Combined With Immune Checkpoint Blockade Against Melanoma
    Yanning Wang, Tianyun Gao, Feifei Huang +8
    MedCommPeer-reviewedCC BYFull textSystems & synthetic biologyDOAJ
  5. 345 Neoantigen-targeted adoptive cell therapy in bladder cancer: feasibility of isolating and enriching tumor-reactive infiltrating lymphocytes
    Mary Thomas, Shari Pilon-Thomas, Matthew Beatty +13
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
BibTeX
@article{colombo2026comparative,
  title = {{Comparative Analysis of Ovarian Cancer Tumor-Infiltrating T Cells with Those in Melanoma and before and after PD-1 Blockade}},
  author = {Ilaria Colombo and Ksenia Meteleva and Simone C. Stone and Anjelica Hodgson and Nicolas Jacquelot and Aras Toker and Azin Sayad and Jehan Vakharia and Valentin Sotov and Christine Tran and Hal K. Berman and Stephenie Prokopec and Giselle Boukhaled and Lisa Wang and Pamela Soberanis Pina and Neesha Dhani and Amit M. Oza and Marcus O. Butler and Lillian L. Siu and Ben X. Wang and Pamela S. Ohashi and Stephanie Lheureux},
  journal = {Cancer Research Communications},
  year = {2026},
  month = nov,
  doi = {10.1158/2767-9764.crc-26-0011},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0011},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Comparative Analysis of Ovarian Cancer Tumor-Infiltrating T Cells with Those in Melanoma and before and after PD-1 Blockade
AU  - Ilaria Colombo
AU  - Ksenia Meteleva
AU  - Simone C. Stone
AU  - Anjelica Hodgson
AU  - Nicolas Jacquelot
AU  - Aras Toker
AU  - Azin Sayad
AU  - Jehan Vakharia
AU  - Valentin Sotov
AU  - Christine Tran
AU  - Hal K. Berman
AU  - Stephenie Prokopec
AU  - Giselle Boukhaled
AU  - Lisa Wang
AU  - Pamela Soberanis Pina
AU  - Neesha Dhani
AU  - Amit M. Oza
AU  - Marcus O. Butler
AU  - Lillian L. Siu
AU  - Ben X. Wang
AU  - Pamela S. Ohashi
AU  - Stephanie Lheureux
PY  - 2026
DA  - 2026/11/12
JO  - Cancer Research Communications
DO  - 10.1158/2767-9764.crc-26-0011
UR  - https://doi.org/10.1158/2767-9764.crc-26-0011
AB  - CD8+ T cells are involved in natural tumor immune surveillance and are known to play a critical role in mediating responses to programmed cell death protein 1 (PD-1) blockade. High-grade serous ovarian cancer (HGSOC) exhibits intrinsic resistance to immune checkpoint inhibitors (ICI), despite the presence of tumor-infiltrating lymphocytes (TIL) in the tumor immune microenvironment (TIME). In this study, we characterized the phenotype and frequency of TILs in the tumor samples of patients with HGSOC and compared our findings with TILs from melanoma, a tumor highly sensitive to ICI. Melanoma harbored an increased density of CD8+ TILs compared with HGSOC. However, CD8+ T cells from HGSOC tumor samples expressed higher levels of exhaustion markers such as 2B4 and PD-1 compared with the CD8+ melanoma TILs, with evidence for antigen-specific CD8+ TILs. Our study demonstrates that despite the presence of CD8+ T cells that are phenotypically exhausted, there is limited expansion of CD8+ cells after treatment with anti–PD-1 in patients with HGSOC. These data indicate that CD8+ T cells from ovarian cancer express markers associated with antigen specificity and are on the exhaustion trajectory yet are unable to contribute to a measurable antitumor response after PD-1 blockade.  Significance:: By analyzing the TIME in patient-derived samples of HGSOC and comparing them with melanoma, we identify a lower density of CD8+ cells. These cells are characterized by a higher level of immune exhaustion with a poor response after treatment with anti–PD-1.
SN  - 2767-9764
ER  -